Fundraising Fox

Biotech Series C Investors & VC Firms

600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.

B-FLEXION
St. HelierSeed–Late Stage$500K
13 people
Bridge Bank
San FranciscoSeed–Late Stage
16 people
Infinitas Capital
Pre-Seed–Late Stage
16 people
Vertex Venture Management Pte. Ltd.
SingaporePre-Seed–Growth
16 people
Detong Capital
ShanghaiSeed–Late Stage$20M
11 people
Texas Ventures
HoustonSeed–Late Stage
6 people
ISA Ventures
Cedar RapidsPre-Seed–Late Stage$25K – $1M
1 person
JStar Capital Investments
AustinSeed–Late Stage
13 people
MIRAI SOUZOU
TokyoPre-Seed–Growth
Orbia Ventures
BostonSeed–Growth$1M – $6M
6 people
Global BioAccess Fund
New YorkSeries A–Late Stage$10M
11 people
2050 Capital
LondonSeed–Series C$200K – $3M
7 people
TOHOKU University Venture Partners
SendaiPre-Seed–Growth
13 people
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
6 people
Radix Ventures
WarsawSeed–Late Stage$550K – $2.8M
9 people
Tetragon Financial Group Limited
LondonSeries C
12 people
Vision Incubate
KanazawaPre-Seed–Growth
9 people
Korea Investment Partners
SeoulSeed–Late Stage$973K – $50M
17 people
Prospect Venture Partners
Menlo ParkSeed–Late Stage$3M – $5M
3 people
Samho Green Investment, Inc.
SeoulSeed–Late Stage$500K – $10M
11 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
11 people
Outset Ventures
AucklandPre-Seed–Growth$100K – $10M
1 person
Luma Group
BostonSeed–Late Stage
13 people
Pivotal Life Sciences
San FranciscoSeed–Late Stage
13 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.